Prospective single-arm protocol of carvedilol in children with ventricular dysfunction

Pediatric Cardiology

Volumn 27, Issue 3, 2006, Pages 336-342

  Blume, E D ^a   Canter, C E ^b   Spicer, R ^c   Gauvreau, K ^a   Colan, S ^a   Jenkins, K J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Beta blockade; Cardiomyopathy; Carvedilol; Heart failure; Heart transplant; Ventricular dysfunction

Indexed keywords

ATROPINE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; GLUCOSE; HYDRALAZINE; ISOPRENALINE; MILRINONE; NITRATE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; BRADYCARDIA; CARDIOVASCULAR PARAMETERS; CARDIOVERSION; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHORESIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; FORWARD HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART TRANSPLANTATION; HEARTBURN; HUMAN; HYPOGLYCEMIA; INFANT; KAPLAN MEIER METHOD; MALE; MAXIMUM TOLERATED DOSE; MULTICENTER STUDY; NEUROLOGIC DISEASE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UPPER RESPIRATORY TRACT INFECTION; VIRAL GASTROENTERITIS;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; PROPANOLAMINES; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33744829508     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1159-1     Document Type: Article

References (29)

1. Akagi T, Benson LN, Lightfoot NE, et al. (1991) Natural history of dilated cardiomyopathy in children. Am Heart J 121:1502-1506
2. Armstrong WF, Feigenbaum H. (2001) Echocardiography. In: Braunwald E, Zipes DP, Libby P O, Heart Disease. Saunders, Philadelphia, p 166.
3. Arola A, Tuominen J, Ruuskanen O, Jokinen E (1998) Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101:3 Pt 1369-376
4. Azeka E, Franchini Ramires JA, Valler C, Alcides Bocchi E (2002) Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 40:2034-2038
5. Baron PW, Barrow RE, Pierre EJ, Herndon DM (1997) Prolonged use of propanolol safely decreases cardiac work in burned children. J Burn Care Rehab 18:223-227
6. Bristow MR, Gilbert EM, Abraham WT, et al. (1996) for the MOCHA investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94:2807-2816
7. Bruns LA, Chrisant MK, Lamour JM, et al. (2001) Carvedilol as therapy in pediatric heart failure: an initial multi-center experience. J Pediatr 138:505-511
8. Buckhorn R, Bartmus D, Siekmeyer W, et al. (1998) Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. Am J Cardiol 81:1366-1368
9. Burch M, Siddiqi SA, Celermajer DS, et al. (1994) Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72:246-250
10. Chen S, Nouri S, Balfour I, Jureidini S, Appleton RS (1990) Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 15:189-193.
11. Cohn JNS, Fowler MB, Bristow MR, et al. (1997) for the U.S. Carvedilol Heart Failure Study Groups. Safety and efficacy of carvedilol in severe heart failure. J Card Fail 3:173-179
12. Colucci WS, Packer M, Bristow MK, et al. (1996) for the U.S. Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 94:2800-2806
13. Eichhorn EJ, Heesch CM, Barnett JH, et al. (1994) Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 24:1310-1320
14. Friedman RA, Moak JP, Garson A (1991) Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol 18:152-156
15. Frishman WH (1998) Carvedilol. N Engl J Med 339:1759-1765
16. Krum H, Sackner-Bernstein JD, Goldsmith RI, et al. (1995) Double-blind, placebo controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92:1499-1506
17. Laer S, Mir TS, Behn F, et al. (2002) Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. Am Heart J 143:916-922
18. Lechat P, Packer M, Chalon S, et al. (1998) Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98:1184-1191
19. Lewis AB, Chabot M (1991) Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 68:369
20. Matitiau A, Perez-Atayde A, Sanders SP, et al. (1994) Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 90:1310-1318
21. Mehta AV, Subrahmanyam AB, Anand R (1996) Long-term efficacy and safety of atenolol for supraventricular tachycardia in children. Pediatr Cardiol 17:231-236
22. Metra M, Nardi M, Giubbini R, Deilas L (1994) Effects of short- and long-term carvedilol administration on rest and exercise heinodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 24:1678-1687
23. Packer M, Bristow MR, Cohn JN, et al. (1996) for the U.S. Carvedilol Heart Failure Study Groups. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355
24. Packer M, Colucci WS, Sackner-Bernstein JD, et al. (1996) for the PRECISE Study Group. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. Circulation 94:2793-2799
25. Shaddy RE (1998) Beta-blocker therapy in young children with congestive heart failure under consideration for heart transplantation. Am Heart J 136:19-21
26. Shaddy RE, Curtin EL, Sower B, et al. (2002) The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. Am Heart J 144:383-389
27. Shaddy RE, Tani LY, Gidding SS, et al. (1999) Beta-blocker treatment of cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transpl 18:269-274
28. Wiest DB, Garner SS, Uber WE (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890-897
29. Williams RV, Tani LY, Shaddy RE (2002) Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. J Heart Lung Transpl 21:906-909